Participants' satisfaction with colorectal cancer screening programs: A systematic review.

Colorectal neoplasms Early detection of cancer Patient experience Patient satisfaction Systematic review cancer screening

Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 13 06 2023
revised: 12 09 2023
accepted: 15 09 2023
pubmed: 19 9 2023
medline: 19 9 2023
entrez: 18 9 2023
Statut: ppublish

Résumé

Since satisfaction with cancer screening experience can increase adherence to programs and contribute to reduce morbidity and mortality, its assessment is crucial for programs´ effectiveness. Our aim was to conduct a systematic review about satisfaction of participants with organized colorectal cancer screening. We searched relevant scientific databases (MEDLINE, EMBASE, PsycINFO, and CINAHL) from inception to May 2022. We selected cross-sectional studies and clinical trials reporting a quantitative survey-based measure of satisfaction towards CRC screening. A total of 15 studies were included, being published from 1992 to 2019 for an overall number of 21 surveys. Of those, 16 (76%) investigated satisfaction with screening tests (fecal occult blood test, fecal immunochemical test, sigmoidoscopy, colonoscopy, computed tomographic colonography), 4 (19%) with colonoscopy as assessment test after suspicious findings, and 2 (10%) with both the screening and assessment phase. None of the included surveys used a validated questionnaire. Most surveys reported a high level of satisfaction for both screening and further assessment phases. Temporary pain, discomfort, embarrassment, and anxiety while waiting for results were the commonest negative aspects perceived, with some variability across studies and considered procedures. Satisfaction with the information and communication about screening was generally good, but some authors reported participants' sub-optimal understanding of informative material. Satisfaction with CRC screening is generally high, but its evaluation is performed using non-validated instruments, which limits the interpretation of results and prevents comparability of the current body of evidence.

Identifiants

pubmed: 37722458
pii: S0091-7435(23)00286-4
doi: 10.1016/j.ypmed.2023.107706
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107706

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Anna Selva (A)

Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine and Public Health, Universitat Autònoma de Barcelona, Barcelona, Spain; Clinical Epidemiology and Cancer Screening, Parc Taulí Hospital Universitari. Institut i Innovació Parc Taulí (I3PT_CERCA). Univesitat Autònoma de Barcelona., Sabadell, Spain. Electronic address: aselva@tauli.cat.

Giansanto Mosconi (G)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Stefano Cacitti (S)

Health Protection Agency of Pavia, Pavia, Italy.

Anna Odone (A)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Liisa Pylkkanen (L)

Department of Oncology, University of Turku, Turku, Finland.

Ivan Solà (I)

CIBER Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain; Iberoamerican Cochrane Centre. Hospital de la Santa Creu i Sant Pau. Institute of Biomedical Research, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Universitat Autònoma de Barcelona, Spain.

Núria Torà (N)

Cancer Screening Programs, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Catalonia, Spain.

Sara Russo (S)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Ennio Cadum (E)

Health Protection Agency of Pavia, Pavia, Italy.

Silvia Deandrea (S)

Health Protection Agency of Pavia, Pavia, Italy.

Classifications MeSH